Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline and UDCA in ATTR Amyloidosis with Cardiomyopathy
NCT02016365Phase 2Completed
- Sponsor
- Umeå University
- Start
- Feb 2012
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline, ursodeoxycholic acid in transthyretin amyloidosis (ATTR), sponsored by Umeå University. Started Feb 2012; status: completed.
02
Drugs
doxycyclineursodeoxycholic acid
03
Conditions
transthyretin amyloidosis (ATTR)
Beyond the preview
Go deeper on NCT02016365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02016365.